- Home
- OLMA vs LEU Comparison
OLMA vs LEU Comparison
Compare OLMA & LEU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OLMA
- LEU
- Stock Information
- Founded
- OLMA 2006
- LEU 1998
- Country
- OLMA United States
- LEU United States
- Employees
- OLMA N/A
- LEU N/A
- Industry
- OLMA Biotechnology: Pharmaceutical Preparations
- LEU Mining & Quarrying of Nonmetallic Minerals (No Fuels)
- Sector
- OLMA Health Care
- LEU Industrials
- Exchange
- OLMA Nasdaq
- LEU Nasdaq
- Market Cap
- OLMA 525.7M
- LEU 599.9M
- IPO Year
- OLMA 2020
- LEU 1998
- Fundamental
- Price
- OLMA $9.43
- LEU $70.31
- Analyst Decision
- OLMA Strong Buy
- LEU Buy
- Analyst Count
- OLMA 5
- LEU 2
- Target Price
- OLMA $27.00
- LEU $92.00
- AVG Volume (30 Days)
- OLMA 417.7K
- LEU 2.0M
- Earning Date
- OLMA 11-12-2024
- LEU 10-28-2024
- Dividend Yield
- OLMA N/A
- LEU N/A
- EPS Growth
- OLMA N/A
- LEU 50.42
- EPS
- OLMA N/A
- LEU 4.70
- Revenue
- OLMA N/A
- LEU $394,000,000.00
- Revenue This Year
- OLMA N/A
- LEU $25.25
- Revenue Next Year
- OLMA N/A
- LEU $2.84
- P/E Ratio
- OLMA N/A
- LEU $14.93
- Revenue Growth
- OLMA N/A
- LEU 14.94
- 52 Week Low
- OLMA $8.51
- LEU $33.51
- 52 Week High
- OLMA $17.10
- LEU $118.36
- Technical
- Relative Strength Index (RSI)
- OLMA 28.00
- LEU 42.01
- Support Level
- OLMA $11.46
- LEU $72.71
- Resistance Level
- OLMA $13.06
- LEU $95.00
- Average True Range (ATR)
- OLMA 0.80
- LEU 10.97
- MACD
- OLMA -0.23
- LEU -3.54
- Stochastic Oscillator
- OLMA 0.00
- LEU 3.34
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.
About LEU Centrus Energy Corp.
Centrus Energy Corp is engaged in the supply of nuclear fuel and services for the nuclear power industry. It operates through the Low-Enriched Uranium (LEU) and Technical Solutions segments. The LEU segment has two components which include the sale of separative work units and uranium. The Technical Solutions segment provides engineering, design, and manufacturing services to government and private sector customers. The majority of the firm's revenue is derived from the LEU segment. It has a business presence in the U.S. and other countries, of which prime revenue is generated in the U.S.